Login to Your Account



AVEO Regains Rights to Phase II Antibody AV-299

By Catherine Hollingsworth


Friday, October 1, 2010
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription